Literature DB >> 30871970

KCC2 membrane diffusion tunes neuronal chloride homeostasis.

Etienne Côme1, Xavier Marques1, Jean Christophe Poncer1, Sabine Lévi2.   

Abstract

Neuronal Cl- homeostasis is regulated by the activity of two cation chloride co-transporters (CCCs), the K+-Cl- cotransporter KCC2 and the Na+-K+-Cl- cotransporter NKCC1, which are primarily extruding and importing chloride in neurons, respectively. Several neurological and psychiatric disorders including epilepsy, neuropathic pain, schizophrenia and autism are associated with altered neuronal chloride (Cl-) homeostasis. A current view is that the accumulation of intracellular Cl- in neurons as a result of KCC2 down-regulation and/or NKCC1 up-regulation may weaken inhibitory GABA signaling and thereby promote the development of pathological activities. CCC activity is determined mainly by their level of expression in the plasma membrane. Furthermore, CCCs undergo "diffusion-trapping" in the membrane, a mechanism that is rapidly adjusted by activity-dependent post-translational modifications i.e. phosphorylation/dephosphorylation of key serine and threonine residues. This represents probably the most rapid cellular mechanism for adapting CCC function to changes in neuronal activity. Therefore, interfering with these mechanisms may help restoring Cl- homeostasis and inhibition under pathological conditions. This article is part of the special issue entitled 'Mobility and trafficking of neuronal membrane proteins'.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chloride homeostasis; Clustering; Epilepsy; GABAergic transmission; KCC2; Lateral diffusion; NKCC1

Mesh:

Substances:

Year:  2019        PMID: 30871970     DOI: 10.1016/j.neuropharm.2019.03.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Gephyrin Interacts with the K-Cl Cotransporter KCC2 to Regulate Its Surface Expression and Function in Cortical Neurons.

Authors:  Sana Al Awabdh; Florian Donneger; Marie Goutierre; Martial Séveno; Oana Vigy; Pauline Weinzettl; Marion Russeau; Imane Moutkine; Sabine Lévi; Philippe Marin; Jean Christophe Poncer
Journal:  J Neurosci       Date:  2021-11-22       Impact factor: 6.709

Review 2.  Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken.

Authors:  Wolfgang Liedtke
Journal:  Front Mol Neurosci       Date:  2022-05-13       Impact factor: 6.261

3.  KCC2 rs2297201 Gene Polymorphism Might be a Predictive Genetic Marker of Febrile Seizures.

Authors:  Sanja Dimitrijevic; Biljana Jekic; Suzana Cvjeticanin; Aleksandra Tucovic; Tamara Filipovic; Ivana Novaković; Bojana Ivić; Dimitrije Nikolic
Journal:  ASN Neuro       Date:  2022 Jan-Dec       Impact factor: 5.200

4.  The Expanding Therapeutic Potential of Neuronal KCC2.

Authors:  Bor Luen Tang
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

5.  Smoothened receptor signaling regulates the developmental shift of GABA polarity in rat somatosensory cortex.

Authors:  Quentin Delmotte; Mira Hamze; Igor Medina; Emmanuelle Buhler; Jinwei Zhang; Yesser H Belgacem; Christophe Porcher
Journal:  J Cell Sci       Date:  2020-10-23       Impact factor: 5.285

6.  Simultaneous Monitoring of pH and Chloride (Cl-) in Brain Slices of Transgenic Mice.

Authors:  Daria Ponomareva; Elena Petukhova; Piotr Bregestovski
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

7.  SNAP23 regulates KCC2 membrane insertion and activity following mZnR/GPR39 activation in hippocampalneurons.

Authors:  Hila Asraf; Milos Bogdanovic; Noa Gottesman; Israel Sekler; Elias Aizenman; Michal Hershfinkel
Journal:  iScience       Date:  2022-01-07

8.  Decreased spasticity of Baishaoluoshi Decoction through the BDNF/TrKB-KCC2 pathway on poststroke spasticity rats.

Authors:  Le Xie; Yao Xie; Guo Mao; Sijia Cao; Rui Fang; Shen Zhou; Junlin Jiang; Ting Yao; Jianhu Fan; Dong Liu; Dahua Wu; Jinwen Ge
Journal:  Neuroreport       Date:  2021-10-06       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.